Reproductive and hormonal risk factors for luminal, HER2-overexpressing, and triple-negative breast cancer in Japanese women
- PMID: 22328736
- DOI: 10.1093/annonc/mdr613
Reproductive and hormonal risk factors for luminal, HER2-overexpressing, and triple-negative breast cancer in Japanese women
Abstract
Background: Although the clinical relevance of the molecular subtypes of breast cancer is evident, etiological differences among subtypes have not been well established, especially among Asian. Here, we evaluated the hypothesis that the etiologic impact of reproductive and hormonal features differs among molecular subtypes.
Materials and methods: We conducted a case-control study in pre- and postmenopausal Japanese. We examined 706 breast cancer patients and 1412 age- and menopausal status-matched noncancer controls. Immunohistochemical stains for estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 (HER2) were used to classify the cases into 554 luminal (hormone receptor positive), 84 HER2-overexpressing (hormone receptor negative, HER2 positive), and 68 triple-negative cases (hormone receptor negative, HER2 negative). Associations were evaluated using multivariate polytomous logistic regression models.
Results: A significant association was observed between early age at menarche and risk of luminal disease (odds ratios = 1.67, 95% confidence interval: 1.22-2.29; P trend = 0.001). No significant differences in association with parity, age at first live birth, breastfeeding history, age at menopause, or synthetic hormonal use were seen across molecular subtypes of breast cancer.
Conclusions: These findings indicate that reproductive events in adolescence have differential impact on the risk of breast cancer molecular subtypes in Japanese.
Similar articles
-
Parity, hormones and breast cancer subtypes - results from a large nested case-control study in a national screening program.Breast Cancer Res. 2017 Jan 23;19(1):10. doi: 10.1186/s13058-016-0798-x. Breast Cancer Res. 2017. PMID: 28114999 Free PMC article.
-
Association between common risk factors and molecular subtypes in breast cancer patients.Breast. 2013 Jun;22(3):344-50. doi: 10.1016/j.breast.2012.08.005. Epub 2012 Sep 14. Breast. 2013. PMID: 22981738
-
Reproductive and hormonal risk factors for postmenopausal luminal, HER-2-overexpressing, and triple-negative breast cancer.Cancer. 2008 Oct 1;113(7):1521-6. doi: 10.1002/cncr.23786. Cancer. 2008. PMID: 18726992 Free PMC article.
-
Reproductive behaviors and risk of developing breast cancer according to tumor subtype: A systematic review and meta-analysis of epidemiological studies.Cancer Treat Rev. 2016 Sep;49:65-76. doi: 10.1016/j.ctrv.2016.07.006. Epub 2016 Jul 29. Cancer Treat Rev. 2016. PMID: 27529149 Review.
-
Reproductive risk factors and breast cancer subtypes: a review of the literature.Breast Cancer Res Treat. 2014 Feb;144(1):1-10. doi: 10.1007/s10549-014-2852-7. Epub 2014 Jan 30. Breast Cancer Res Treat. 2014. PMID: 24477977 Free PMC article. Review.
Cited by
-
The unique risk factor profile of triple-negative breast cancer: a comprehensive meta-analysis.J Natl Cancer Inst. 2024 Aug 1;116(8):1210-1219. doi: 10.1093/jnci/djae056. J Natl Cancer Inst. 2024. PMID: 38445713 Free PMC article.
-
Relationships between Reproductive Risk Factors for Breast Cancer and Tumor Molecular Subtypes.Asian Pac J Cancer Prev. 2018 Jul 27;19(7):1767-1770. doi: 10.22034/APJCP.2018.19.7.1767. Asian Pac J Cancer Prev. 2018. PMID: 30049185 Free PMC article.
-
Protooncogenic Role of ARHGAP11A and ARHGAP11B in Invasive Ductal Carcinoma: Two Promising Breast Cancer Biomarkers.Biomed Res Int. 2023 Nov 23;2023:8236853. doi: 10.1155/2023/8236853. eCollection 2023. Biomed Res Int. 2023. PMID: 38046902 Free PMC article.
-
Comparison of breast cancer risk factors among molecular subtypes: A case-only study.Cancer Med. 2019 Apr;8(4):1882-1892. doi: 10.1002/cam4.2012. Epub 2019 Feb 14. Cancer Med. 2019. PMID: 30761775 Free PMC article.
-
Parity, hormones and breast cancer subtypes - results from a large nested case-control study in a national screening program.Breast Cancer Res. 2017 Jan 23;19(1):10. doi: 10.1186/s13058-016-0798-x. Breast Cancer Res. 2017. PMID: 28114999 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous